Vanadium and diabetes

Molecular and Cellular Biochemistry

Volumn 188, Issue 1-2, 1998, Pages 73-80

  Poucheret, Patrick ^a   Verma, Subodh ^a   Grynpas, Marc D ^b   McNeill, John H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Diabetes; Glucose lowering; Insulin mimetic; Vanadium

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; INSULIN RECEPTOR; PROTEIN SERINE THREONINE KINASE; TRIACYLGLYCEROL; VANADIUM DERIVATIVE; VANADYL SULFATE;

BONE STRENGTH; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; DEPHOSPHORYLATION; DIABETES MELLITUS; DRUG ABSORPTION; DRUG MECHANISM; DRUG POTENCY; DRUG SYNTHESIS; ENZYME ACTIVATION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; HYPOGLYCEMIC AGENTS; VANADIUM;

ANIMALIA;

EID: 0031725260     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006820522587     Document Type: Conference Paper

References (67)

1. Heyliger CE, Tahiliani AG, McNeill JH: Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227: 1474 1477,1985
2. Nechay BR: Mechanism of action of vanadium. Ann Rev Pharmacol Toxicol 24: 501 524,1984
3. Talvite NA, Wagner WD: Studies in vanadium toxicology. Arch Ind Hyg Occup Med 9: 414 422,1954
4. Byrne AR, Kosta L: Vanadium in food and human body fluids and tissues. Sci Total Environ 10: 17 30,1993
5. Nakai M, Watanabe B, Fujiwara C, Kakegawa H, Satoh T, Takeda J, Matsushita R, Sakurai H: Mechanism of insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds. J Pharm Soc Jap 18: 119 125,1995
6. Duckworth WC, Solomon SS, Liepneks J, Hamel FG, Hand S, Peavy DE: Insulin like effects of vanadate in isolated rat adipocytes. Endocrinology 122: 2285 2289,1988
7. Schechter Y, Karlish SJD: Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions. Nature 284: 556 558,1980
8. Tamura S, Brown TA, Whipple JH, Fujita-Yamaguchi Y, Dubler RE, Cheng K, Lamer J: A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. J Biol Chem 259: 6650 6658,1984
9. Tamura S, Brown TA, Dubler RE, Lamer J: Insulin-like effect of vanadate on adipocyte glycogen synthase and on phosphorylation of 95,000 Dalton subunit of insulin receptor. Biochem Biophys Res Comm 113: 8042 8048,1983
10. McNeill JH, Yuen VG, Dai S, Orvig C: Increased potency of vanadium using organic ligands. Mol Cell Biochem 153: 175 180,1995
11. Orvig C, Thompson KH, Battell M, McNeill JH: Vanadium compounds as insulin mimics in 'Metal Ions in Biological Systems' In: H. Sigel and A. Sigel (eds). Marcel Dekker, Inc,1995
12. Jackson T, Salhanick AL, Sparks JD, Sparks CE, Bolognino M, Amatrude JM: Insulin-mimetic effects of vanadate in primary cultures of rat hepatocytes. Diabetes 37: 1234 1240,1988
13. Morita T, Imagawa T, Kanagawa A, Ueki H: Sodium orthovanadate increases phospholipase A2 activity in isolated rat fat pats: A role of phospholipase A2 in the vanadate stimulated release of lipoprotein lipase activity. Biol Pharm Bull 18: 347 349,1995
14. Maher PA: Stimulation of endothelial cell proliferation by vanadate specific for microvascular endothelial cells. J Cell Physiol 151: 549 554,1992
15. Barnes DM, Sykes DB, Schechter Y, Miller DS: Multiple sites of vanadate and peroxovanadate action in xenopus oocytes. J Cell Physiol 162: 154 161,1995
16. Hajjar JJ, Fucci JC, Rowe WA, Tomicic TK: Effect of vanadate on amino acid transport in rat jejunum. Proc Nail Acad Sci USA 184: 403 409,1987
17. Bhanot S, Bryer-Ash M, Cheung A, McNeill JH: Bis(maltolato) oxovanadium (IV) attenuates hyperinsulinemia and hypertension in spontaneously hypertensive rats. Diabetes 43: 857 861,1994
18. Meyerovitch J, Farfel Z, Sack J, Schechter Y: Oral administration of vanadate normalizes blood glucose levels in streptozotocin treated rats. J Biol Chem 262: 6658 6662,1987
19. Brichard SM, Okitolonda W, Henquin JC: Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology 123: 2048 2053,1988
20. Hudson TGF: Vanadium, Toxicology and Biological Significance. New York, Elsevier,1964
21. Battell ML, Yuen VG, McNeill JH: Treatment of BB rats with vanadyl sulfate. Pharmacol Commun 1: 291 301,1992
22. Ramanadham S, Mongold JJ, Brownsey RW, Cros GH, McNeill JH: Oral vanadyl sulfate treatment of diabetes mellitus in rats. Am J Physiol 257: 11904 11911,1989
23. Ramanadham S, Brownsey RW, Cros GH, Mongold JJ, McNeill JH: Sustained prevention of myocardial abnormalities in diabetic rats following withdrawal from oral vanadyl treatment. Metabolism 38: 1022 1028,1989
24. Cam MC, Pederson RA, Brownsey RW, McNeill JH: Long term effectiveness of oral vanadyl sulfate in streptozotocin-diabetic rats. Diabetologia 36: 218 224,1993
25. Ramanadham S, Cros GH, Mongold JJ, Serrano JJ, McNeill JH: Enhanced in vivo sensitivity of vanadyl treated diabetic rats to insulin. Can J Physiol Pharmacol 68: 486 491,1990
26. McNeill JH, Yuen VG, Hoveyda HR, Orvig C: Bis(maltolato) oxovanadium (IV) is a potent insulin mimic. J Med Chem 35: 1489 1491,1992
27. Yuen VG, Orvig C, McNeill JH: Glucose lowering effects of a new organic vanadium complex bis(maltolato)oxovanadium (IV). Can J Physiol Pharmacol 71: 263 269,1993
28. Yuen VG, Orvig C, McNeill JH: Comparison of the glucose lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium (IV) following acute and chronic administration. Can J Physiol Pharmacol 73: 55 64,1995
29. Dai S, Yuen VG, Orvig C, McNeill JH: Prevention of diabetes-induced pathology in STZ-diabetic rats by bis(maltolato)oxovanadium (IV). Pharmacol Communic 3: 311 321,1993
30. Yuen VG, Pederson RA, Dai S, Orvig C, McNeill JH: The effects of low and high dose administration of bis(maltolato)oxovanadium (IV) on fa/fa Zucker rats. Can J Physiol Pharmacol 74: 1001 1009,1996
31. Bhanot S, McNeill JH: Insulin and hypertension: A causal relationship? Cardiovasc Res 31: 212 221,1996
32. DeFronzo RA, Ferrannini E: Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14: 173 194,1991
33. Ferrannini E, Natali A: Essential hypertension, metabolic disorders and insulin resistance. Am Heart J 121:1274-1282,1991
34. Bhanot S, Michoulas A, McNeill JH: Antihypertensive effects of vanadium compounds in hyperinsulinemic, hypertensive rats. Mole Cell Biochem 153: 205 209,1995
35. Bhanot S, McNeill JH: Vanadyl sulfate lowers plasma insulin levels and blood pressure in spontaneously hypertensive rats. Hypertension 24: 625 632,1994
36. Bhanot S, McNeill JH, Bryer-Ash M: Vanadyl sulfate prevents fructose induced hyperinsulinemia and hypertension in rats. Hypertension 23: 308 312,1994
37. Swarup G, Cohen S, Garbers DI: Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem Biophys Res Com 107: 1104 1109,1982
38. Tracey AS, Gresser MJ: Interaction of vanadate with phenol and tyrosine: implications for the effects of vanadate on systems regulated by tyrosine phosphorylation. Proc Natl Acad Sci USA 83: 609 613,1986
39. Ueno A, Arakaki N, Takeda Y, Fujio H: Inhibition of tyrosine autophosphorylation of the solubilized insulin receptor by an insulin stimulating peptide derived from bovine serum albumin. Biochem Biophys Res Com 144: 11 18,1987
40. Gherzi R, Caratti G, Andraghetti G, Bertolini S, Montemurro A, Sesto G, Cordera R: Direct modulation of insulin receptor protein tyrosine kinase by vanadate and antiinsulin receptor monoclonal antibodies. Biochem Biophys Res Com 152: 1474 1480,1988
41. Smith DM, Sale GJ: Evidence that a novel serine kinase catalyses phosphorylation of the insulin receptor in an insulin dependent and tyrosine kinase dependent manner. Biochem J 256: 903 909,1988
42. Green A: The insulin like effect of sodium vanadate on adipocyte transport is mediated at a post insulin receptor level. Biochem J 238: 663 669,1993
43. Mooney RA, Bordwell KL, Luhowskyj S, Casnelle JE: The insulin like effect of vanadate on lipolysis in rat adipocytes is not accompanied by an insulin like effect on tyrosine phosphorylation. Endocrinology 124: 422 429,1989
44. Shisheva A, Shechter Y: Role of cytosolic tyrosine kinase in mediating the insulin like actions of vanadate in rat adipocytes. J Biol Chem 268: 6463 6469,1993
45. Shechter Y, Shisheva A, Lazar R, Libman J, Shanzer A: Hydrophobic carriers of vanadyl ions augment the insulinomimetic actions of vanadyl ions in rat adipocytes. Biochemistry 31: 2063 2068,1982
46. Sekar N, Li J, Schechter Y: Vanadium salts as insulin substitutes: Mechanism of action, a scientific and therapeutic tool in diabetes mellitus research. Critical Rev Biochem Mol Biol 31: 339 359,1996
47. Hei YJ, Chen X, Pelech SL, Diamond J, McNeill JH: Skeletal muscle mitogen activated protein kinases and ribosomal S6 kinases suppression in chronic diabetes and reversal by vanadium. Diabetes 44: 1147 1155,1995
48. Hei YJ, Diamond J, McNeill JH: Distribution of MAP kinase, S6 kinase and casein kinase 2 in rat tissues: activation by insulin in spleen. Biochem Cell Biol 72: 49 53,1994
49. Cam MC, Li WM, McNeill JH: Partial preservation of pancreatic beta cells by vanadium: Evidence for chronic amelioration of diabetes. Metabolism 46: 1 11,1997
50. Goldfine AB, Simonson DC, Folli F, Patti ME, Khan CR: Metabolic effects of sodium metavanadate in humans with insulin dependent and non insulin dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab 80: 3311 3320,1995
51. Cohen N, Halberstam M, Shlimovich P, Chang CJ, Shamoon H, Rossetti L: Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non insulin dependent diabetes mellitus. J Clin Invest 95: 2501 2509,1995
52. Boden G, Chen S, Ruiz J, George DV, Rossum V, Turco S: Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non insulin dependent diabetes mellitus. Metabolism 45: 1130 1135,1996
53. Halberstam M, Cohen N, Shlimovich P, Rossetti L, Shamoon H: Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese non diabetic subjects. Diabetes 45: 659 666,1996
54. Malabu US, Dryden S, McCarthy HD, Kilpatrick A, Williams G: Effects of chronic vanadate administration in the STZ diabetic rat. The antihyperglycemic action of vanadate is attributable entirely to its suppression of feeding. Diabetes 43: 9 15,1994
55. Yuen VG, Orvig C, McNeill JH: Effects of bis(maltolato) oxovanadium (IV) are distinct from food restriction in STZ-diabeticrats. Am J Physiol 272: E30 E35,1997
56. Mravoca A, Jirova D, Janci H and Lener J: Effect of orally administered vanadium on the immune system and bone metabolism in experimental animals. The Science of the Total Environment (Supplement), Elsevier Publishers, Amsterdam, 1993, pp 663 669
57. Yuen VG, Orvig C, Thompson KH, McNeill JH: Improvement in cardiac dysfunction in STZ-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium (IV). Can J Physiol Pharmacol 71: 270 276,1993
58. Mongold JJ, Cros GH, Vian L, Tep A, Ramanadham S, Siou G, Diaz J, McNeill JH, Serrano JJ; Toxicological aspects of vanadyl sulfate on diabetic rats - Effects on vanadium levels and pancreatic B-cell morphology. Pharmacol Toxicol 67: 192 198,1990
59. Blondel O, Bailbe D, Portha B: In vivo insulin resistance in streptozotocin-diabetic rats - evidence for reversal following vanadate treatment. Diabetologia 32: 185 190,1989
60. Gil J, Miralpeix M, Carreras J, Bartrons R: Insulin like effects of vanadate on glucokinase activity and fructose 2,6 biphosphate levels in livers of diabetic rats. J Biol Chem 263: 1868 1871,1988
61. Pugazhenthi S, Khandelwal R: Insulin like effects of vanadate on hepatic glycogen metabolism in non-diabetic and streptozotocin-induced diabetic rats. Diabetes 39: 821 827,1990
62. Brichard SM, Debuquois B, Girard J: Vanadate treatment of diabetic rats reverses the impaired expression of genes involved in hepatic glucose metabolism: effects on glycolytic and gluconeogenic enzymes and on glucose transporter GLUT2. Mol Cell Endocrinol 91: 91 97,1993
63. Thompson KH and McNeill JH: Effect of vanadyl sulfate feeding on susceptibility to peroxidative change in diabetic rats. Res Comm Chem Path Pharmacol 80: 187 200,1993
64. Rossetti L, McLaughlin MR: Correction of chronic hyperglycemia by vanadate but not with phlorizin, nonnalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle. J Clin Invest 84: 892 899,1989
65. Blondel O, Simon J, Chevalier B, Portha B: Impaired insulin action but normal insulin receptor activity in diabetic rat liver: Effect of vanadate. Am J Physiol 258: E459 E467,1990
66. Brichard SM, Pottier AM, Henquin JC: Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats. Endocrinology 125: 2510 2516,1989
67. Brichard SM, Bailey CJ, Henquin JC: Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate. Diabetes 39: 1326 1332,1990